Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Кафедра психиатрии ФУВ РГМУ, Москва
Список исп. литературыСкрыть список 1. Kessler RC. Evidence that generalized anxiety disorder is an independent disorder. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd 2002; p. 3–10. 2. Старостина Е.Г. Генерализованное тревожное расстройство и симптомы тревоги в общемедицинской практике. Рус. мед. журн. 2004; 12 (22): 1277–83. 3. Weisberg RB. Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiat 2009; 70 (Suppl. 2): 4–9. 4. Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiat 2009; 70 (Suppl. 2): 20–4. 5. Wittchen H, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiat 1994; 51: 355–64. 6. Wittchen H, Beesdo K, Kessler RC. The impact of generalized anxiety disorder. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd 2002; p. 11–26. 7. Hawgood J, De Leo D. Anxiety disorders and suicidal behaviour: an update. Curr Opin Psychiat 2008; 21 (1): 51–64. 8. Allgulander C. Generalized anxiety disorder: between now and DSM-V. Psychiatr Clin North Am 2009; 32 (3): 611–28. 9. Behar E, DiMarco ID, Hekler EB et al. Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. J Anxiety Disord 2009; 23 (8): 1011–23. 10. Stein DJ, Rickels K, Nutt D. Generalized anxiety disorder: the way forward. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd 2002; p. 187–95. 11. Rickels K, Rynn MA. What is generalized anxiety disorder? J Clin Psychiat 2001; 62 (Suppl. 11): 4–12. 12. Rickels K, Rynn M. Overview and clinical presentation of generalized anxiety disorder. Psychiat Clin North Am 2001; 24 (1): 1–17. 13. Raj A, Sheehan DV. Antidepressants in the treatment of generalized anxiety disorder. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd 2002; p. 137–52. 14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand 1983; 67 (6): 361–70. 15. Краснов В.Н., Довженко Т.В., Бобров А.Е. и др. Распространенность психических расстройств у больных первичной медицинской практики в Москве и методы их выявления. Актуальные вопросы внебольничной психоневрологической помощи детскому и взрослому населению: избранные труды. Материалы научно-практической конференции с международным участием, Санкт-Петербург, 21–22 мая 2009 г. Под ред. Н.Г.Незнанова. СПб.: Изд. СПб науч.-иссл. психоневрол. ин-та им. В.М.Бехтерева, 2009; с. 157–8. 16. Spitzer RL, Kroenke K, Williams JB, LЪwe BA. Brief measure for assessing generalized anxiety disorder. The GAD-7. Arch Intern Med 2006; 166: 1092–7. 17. Seitz DP. Screening mnemonic for generalized anxiety disorder. Canad Fam Physician 2005; 5: 1340–2. 18. МКБ-10. Классификация психических и поведенческих расстройств (исследовательские критерии). ВОЗ. Женева, 1994. 19. APA. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed., text revision. 2000. 20. Старостина Е.Г., Мошняга Е.Н., Бобров А.Е. Особенности течения сахарного диабета при тревожных расстройствах. Материалы IV Всероссийского диабетологического конгресса. Москва, 19–22 мая 2008 г., с. 290. 21. Nutt DJ. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 2005; 10 (1): 49–56. 22. Borkovec TD. Psychological aspects and treatment of generalized anxiety disorder. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd, 2002; p. 99–110. 23. Hoyer J, Beesdo K, Gloster AT et al. Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder. Psychother Psychosom 2009; 78 (2): 106–15. 24. Allgulander C. Novel approaches to treatment of generalized anxiety disorder. Curr Opin Psychiat 2010; 23 (1): 37–42. 25. Chouinard G. The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. J Psychiat Neurosci 2006; 31 (3): 168–76. 26. Kistorp TK, Laursen SB. Herbal medicines-evidence and drug interactions in clinical practice. Ugeskr Laeger 2002; 164 (36): 4161–5. 27. Davidson JR. First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiat 2009; 70 (Suppl. 2): 25–31. 28. Rynn MA, Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr 2004; 9 (10): 716–23. 29. Carter NJ, McCormack PL. Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs 2009; 23 (6): 523–41. 30. Khalid-Khan S, Rynn M, Rickels K. Buspirone and antihistamines in the treatment of generalized anxiety disorder. In: D.Nutt, K.Rickels, D.Stein (eds.) Generalized anxiety disorder. Symptomatology, pathogenesis and management. Martin Dunitz Ltd 2002; p. 125–36. 31. Hindmarch I. Cognition and anxiety: the cognitive effects of anti-anxiety medication. Acta Psychiat Scand 1998; 98 (Suppl. 393): 89–94. 32. Аведисова А.С., Чахава В.О., Борукаев Р.Р. Эффективность афобазола при генерализованном тревожном расстройстве в условиях длительной терапии. Психиат. и психофармакотер. 2008; 10 (5): 20–3. 33. Gao K, Sheehan DV, Calabrese JR. Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. Expert Rev Neurother 2009; 9 (8): 1147–58.